FFRangio System vs Biograph VK10

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CathWorks (acquired by Medtronic)
VS
by Siemens Healthineers

AI Verdict

These tools are adjacent rather than direct competitors, as they serve distinct purposes within cardiovascular care. The FFRangio System focuses on providing wire-free functional assessment of coronary artery disease to optimize PCI decisions, leveraging AI for angiogram analysis. In contrast, the Biograph VK10 is a combined PET/CT scanner designed for high-resolution diagnostic imaging across various conditions, including cardiovascular, by providing anatomical and metabolic insights.

Choose FFRangio System if…

Choose the FFRangio System if you are an interventional cardiologist seeking real-time, wire-free, and drug-free functional guidance to optimize and confirm PCI decisions for patients with coronary artery disease. This system is ideal for quickly assessing the physiological impact of lesions and planning interventions directly within the cath lab, leveraging AI for angiogram analysis and eliminating the need for invasive pressure wires.

View FFRangio System →

Choose Biograph VK10 if…

Choose the Biograph VK10 if you require high-resolution combined PET/CT imaging for the comprehensive detection, diagnosis, staging, or restaging of a wide range of diseases, including cancer, cardiovascular, and neurological conditions. This system is best suited for scenarios where detailed metabolic and anatomical information fusion is critical for precise disease characterization and treatment planning.

View Biograph VK10 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature FFRangio System Biograph VK10
Pricing Contact vendor for pricing information. Unknown
Deployment SaaS, on-prem, hybrid On-premise (integrated system)
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Biograph VK10

While Tool A emphasizes an intuitive user interface and ease of use for its specific cath lab workflow, Tool B, as a complex imaging system, offers a broader range of usability enhancements. These include an AI-powered interface to guide users, remote tablet control for efficiency, and features like an integrated patient camera and Moodlight system to improve both staff and patient experience.

Clinical Value

FFRangio System

Tool A provides a disruptive, less invasive method for functional assessment of coronary artery disease, directly impacting PCI decisions by eliminating the need for invasive wires and drugs, and reducing radiation exposure. Its high diagnostic accuracy compared to traditional FFR wires is a substantial clinical advancement. Tool B offers high-resolution diagnostic imaging across multiple specialties, but Tool A's innovation in replacing an invasive procedure offers a more distinct clinical advantage.

Pricing & Value

FFRangio System

Both tools require direct contact for pricing, which is typical for medical devices of this nature. However, Tool A has published clinical trial data demonstrating significant economic advantages and reduced overall costs compared to traditional wire-based FFR. This transparency regarding cost-effectiveness provides a clearer picture of its value proposition.

Enterprise Readiness

Biograph VK10

Tool B explicitly states HIPAA compliance with a Business Associate Agreement (BAA) and highlights robust cybersecurity controls in accordance with FDA guidance. While Tool A has ISO 27001 and 13485 certifications, its HIPAA compliance is not explicitly stated as 'yes' in the provided facts, giving Tool B a stronger documented stance on enterprise readiness.

Innovation

FFRangio System

Tool A introduces a truly disruptive innovation by enabling non-invasive, wire-free, and drug-free FFR assessment using AI and routine angiograms, fundamentally changing the approach to coronary physiology assessment. While Tool B offers advancements in imaging technology with SiPM and high-resolution CT, it represents an evolution of existing PET/CT systems rather than a paradigm shift in diagnostic methodology.

Support & Docs

Biograph VK10

Siemens, as a large and established medical technology company, provides a comprehensive support ecosystem, including an online academy for user training, operator and service manuals, and a global service network. While CathWorks offers Instructions for Use and patient education, the sheer scale and established infrastructure of Siemens likely provide more extensive and readily accessible support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature FFRangio System Biograph VK10
Name FFRangio System Biograph VK10
Company CathWorks Siemens Medical Solutions USA, Inc.
Primary Function Delivers wire-free and drug-free 3D FFR guidance for optimizing and confirming PCI decisions. Provides high-resolution combined PET/CT imaging for detection and diagnosis of various diseases.
Tagline A New Era in Coronary Physiology Precision PET/CT Imaging for Advanced Disease Detection and Diagnosis
Categories Cardiology AI, Surgical AI Cardiology AI, Neurology AI, Oncology AI
Specialties Cardiology Nuclear Medicine, Radiology

Videos

Demos, reviews, and walkthroughs featuring FFRangio System and Biograph VK10.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The FFRangio System is designed for optimizing and confirming PCI decisions in patients with coronary artery disease, primarily serving Cardiology. The Biograph VK10 is a combined PET/CT scanner for high-resolution imaging, aiding in the detection and diagnosis of various diseases across Cardiology, Neurology, Oncology, Nuclear Medicine, and Radiology specialties.
The FFRangio System utilizes artificial intelligence to analyze angiograms, providing wire-free and drug-free 3D FFR guidance and real-time FFRangio values. In contrast, the Biograph VK10 is a combined PET/CT imaging system featuring an air-cooled Silicon Photomultiplier (SiPM) PET system and an updated CT subsystem for high-resolution metabolic and anatomic registration and fusion.
The FFRangio System eliminates the need for invasive pressure wires, drugs, or a guide catheter, offering a wire-free and drug-free approach to FFR guidance. The Biograph VK10 provides high-resolution, non-invasive combined PET/CT imaging for comprehensive disease detection and diagnosis.
The FFRangio System is ISO 27001 certified for information security and handles protected health information (PHI), with a Business Associate Agreement (BAA) likely, though not explicitly stated as HIPAA compliant. The Biograph VK10 is explicitly stated as HIPAA compliant with proper implementation and a Business Associate Agreement (BAA) in place, reflecting Siemens Healthineers' commitment to data privacy and security.
The FFRangio System is an on-premise solution designed for seamless integration with cath lab equipment, C-arm angiography systems, and PACS. The Biograph VK10 is also an on-premise medical device, offering enhanced workflows and patient handling improvements for its combined PET/CT imaging capabilities.
The FFRangio System provides real-time FFRangio values, a simulated pullback curve to differentiate functional patterns of CAD, and a Lesion Impact feature to assess residual ischemia. The Biograph VK10 offers high-resolution metabolic and anatomic registration and fusion, aiding in detecting, localizing, diagnosing, staging, and restaging various diseases.
AI Tool Finder
AI-powered search. Results may not be comprehensive.